Functional Characterization of Herpesvirus-Activated Noncoding Retrotransposon RNAs
疱疹病毒激活的非编码反转录转座子 RNA 的功能表征
基本信息
- 批准号:9975697
- 负责人:
- 金额:$ 18.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-10 至 2021-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAntiviral AgentsAntiviral ResponseBlindnessCell NucleusCellsCellular StressChickenpoxChromatinCodeComplexCytoplasmDNA Polymerase IIIDNA Virus InfectionsDNA VirusesDataDiseaseDouble-Stranded RNAElementsEpigenetic ProcessEukaryotic CellExposure toGene ExpressionGene Expression ProfileGenesGenetic TranscriptionGenomeHerpes zoster diseaseHerpesviridaeHerpesviridae InfectionsHerpesvirus Type 3HomeostasisHost DefenseHumanHuman Herpesvirus 8Immune systemImmunizationIn VitroIndividualInfectionInflammatory ResponseInnate Immune ResponseInterferonsLinkMalignant NeoplasmsMapsMediatingMessenger RNAMissense MutationModalityMusNatural ImmunityNuclearOutcomePathologyPathway interactionsPatternPlasmidsPlayPolymeraseProductionProteinsRNARNA Polymerase IIIRegulator GenesRepetitive SequenceResearchRetrotransposonRoleShapesSignal PathwaySignal TransductionSomatic CellTechnologyTestingTissuesTranscriptTranscriptional RegulationUntranslated RNAViralViral PathogenesisVirus DiseasesVirus Replicationantiviral immunitycell typecytokineexperimental studygammaherpesvirusimmune activationinnate immune pathwaysinsightpathogenpathogenic virusresponsesensortripolyphosphate
项目摘要
The advancement of sequencing technologies has resulted in the discovery of numerous types of non-coding
RNAs (ncRNA) that play important role in both tissue homeostasis and disease pathology. Additionally, several
studies have identified host and pathogen-encoded ncRNA whose expression patterns are associated with
viral pathogenesis, host defense and activation from latency. One specific class of ncRNA that has been
shown to modulate viral replication and inflammatory responses in mouse and human cells, respectively, are
the short interspersed nuclear elements (SINEs), termed B1-B4 in mice and Alu in humans. These repetitive
elements are epigenetically silenced in healthy somatic cells but can be induced and transcribed by RNA
polymerase III (Pol3) upon exposure to various cellular stresses
, including infection with a variety of DNA
viruses. Recent studies suggest that SINE ncRNA expression can influence viral and host gene expression
and NFκB signaling during infection with the murine gammaherpesvirus MHV68, a close relative of Kaposi's
sarcoma-associated herpesvirus. Additional studies have linked SINE expression to increased transcription of
interferon-stimulated genes (ISG) . Given that SINE ncRNAs accumulate in the nucleus and the
cytoplasm, how their gene regulatory and signaling activities are coordinated in each compartment is a
fundamental question in the field. We will address this by first constructing a SINE locus activation map in
cells infected with alpha or gammaherpesviruses, which will be used to identify direct SINE ncRNA-driven gene
expression signatures in the nucleus and their consequences for viral replication. We will then identify which
components of the innate immune pathway in the cytoplasm are involved in sensing natively transcribed SINE
ncRNAs. Collectively, these results will provide new mechanistic insights into how these “self” ncRNAs function
to influence the gene expression landscape during DNA virus infection.
测序技术的进步已经导致发现了许多类型的非编码基因。
RNA(ncRNA)在组织稳态和疾病病理学中起重要作用。此外,若干
研究已经鉴定了宿主和病原体编码的ncRNA,其表达模式与
病毒的发病机制、宿主防御和潜伏激活。一类特殊的ncRNA,
显示分别在小鼠和人细胞中调节病毒复制和炎症反应,
短散在核元件(西内斯),在小鼠中称为B1-B4,在人类中称为Alu。这些重复
在健康的体细胞中,表观遗传沉默元件,但可以被RNA诱导和转录
聚合酶III(Pol 3)在暴露于各种细胞应激时
包括感染多种DNA
病毒最近的研究表明,SINE ncRNA的表达可以影响病毒和宿主基因的表达
小鼠γ疱疹病毒MHV 68(Kaposi的近亲)感染期间NFκB信号传导
肉瘤相关疱疹病毒另外的研究已经将SINE表达与转录的增加联系起来,
干扰素刺激基因(ISG)。鉴于SINE ncRNA在细胞核中积累,
细胞质中,它们的基因调控和信号传导活动如何在每个隔室中协调,
这个领域的基本问题。我们将通过首先构建一个SINE位点激活图来解决这个问题。
感染α或γ疱疹病毒的细胞,其将用于鉴定直接SINE ncRNA驱动的基因
细胞核中的表达特征及其对病毒复制的影响。然后我们将确定
细胞质中先天免疫途径的组分参与感知天然转录的SINE
ncRNA。总的来说,这些结果将为这些“自我”ncRNA的功能提供新的机制见解
影响DNA病毒感染期间的基因表达景观。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Britt A Glaunsinger其他文献
Britt A Glaunsinger的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Britt A Glaunsinger', 18)}}的其他基金
2023 Viruses and Cells Gordon Research Conference and Gordon Research Seminar
2023病毒与细胞戈登研究大会暨戈登研究研讨会
- 批准号:
10609208 - 财政年份:2023
- 资助金额:
$ 18.9万 - 项目类别:
Regulation of Gammaherpesviral Late Gene Expression
γ疱疹病毒晚期基因表达的调控
- 批准号:
9178643 - 财政年份:2015
- 资助金额:
$ 18.9万 - 项目类别:
Regulation of Gammaherpesviral Late Gene Expression
γ疱疹病毒晚期基因表达的调控
- 批准号:
10368981 - 财政年份:2015
- 资助金额:
$ 18.9万 - 项目类别:
Regulation of Gammaherpesviral Late Gene Expression
γ疱疹病毒晚期基因表达的调控
- 批准号:
10223851 - 财政年份:2015
- 资助金额:
$ 18.9万 - 项目类别:
Regulation of Gammaherpesviral Late Gene Expression
γ疱疹病毒晚期基因表达的调控
- 批准号:
9049040 - 财政年份:2015
- 资助金额:
$ 18.9万 - 项目类别:
Disruption of Cellular RNA Processing by Kaposi's Sarcoma-Associated Herpesvirus
卡波西肉瘤相关疱疹病毒对细胞 RNA 加工的破坏
- 批准号:
9317435 - 财政年份:2015
- 资助金额:
$ 18.9万 - 项目类别:
Regulation of Gammaherpesviral Late Gene Expression
γ疱疹病毒晚期基因表达的调控
- 批准号:
10576837 - 财政年份:2015
- 资助金额:
$ 18.9万 - 项目类别:
Escape from gammaherpesvirus-induced mRNA destruction
逃避伽马疱疹病毒诱导的 mRNA 破坏
- 批准号:
8148069 - 财政年份:2011
- 资助金额:
$ 18.9万 - 项目类别:
Escape from gammaherpesvirus-induced mRNA destruction
逃避伽马疱疹病毒诱导的 mRNA 破坏
- 批准号:
8309954 - 财政年份:2011
- 资助金额:
$ 18.9万 - 项目类别:
Escape from gammaherpesvirus-induced mRNA destruction
逃避伽马疱疹病毒诱导的 mRNA 破坏
- 批准号:
8459030 - 财政年份:2011
- 资助金额:
$ 18.9万 - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
$ 18.9万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 18.9万 - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
$ 18.9万 - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
$ 18.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
$ 18.9万 - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
$ 18.9万 - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
$ 18.9万 - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 18.9万 - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
$ 18.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
$ 18.9万 - 项目类别:














{{item.name}}会员




